Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 25,098 shares, a drop of 93.8% from the July 15th total of 402,126 shares. Based on an average daily volume of 15,813 shares, the short-interest ratio is presently 1.6 days. Currently, 0.0% of the company’s stock are short sold.
Raia Drogasil Stock Performance
RADLY traded down $0.26 during trading hours on Tuesday, hitting $3.56. 5,629 shares of the company’s stock were exchanged, compared to its average volume of 160,096. Raia Drogasil has a 1-year low of $3.01 and a 1-year high of $5.34. The stock’s 50-day moving average is $3.57 and its two-hundred day moving average is $4.20.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. The business had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Research analysts forecast that Raia Drogasil will post 0.17 EPS for the current fiscal year.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Stories
- Five stocks we like better than Raia Drogasil
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
